Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. AbbVie Bioresearch Center
EIR
•AbbVie Bioresearch Center•May 24, 2018

AbbVie Bioresearch Center – FDA EIR, May 24, 2018

Record Details

An FDA inspection of AbbVie Bioresearch Center, Inc. in Worcester, MA, was conducted from May 15-24, 2018. This Level II GMP inspection, performed under Compliance Program 7345.848 for Biological Drug Products regulated by CBER, focused on the Quality, Materials, Production, and Facilities & Equipment Systems. At the inspection's conclusion, a three-item FDA Form 483 was issued, detailing significant observations. Key violations included an inadequate investigation into residue found in a drug substance, leading to the release of a lot without root cause identification or additional testing. The qualification of a new cold room was also found deficient, lacking essential temperature mapping data for "worst-case" scenarios like power failures, and the firm's revised procedures were not retroactively applied. Furthermore, personnel monitoring procedures during aseptic processing were not consistently followed, with an operator compromising a critical component and environmental monitoring samples being processed inadequately. AbbVie management committed to providing a written response to the FDA within 15 business days. The FDA also requested that process changes, such as the use of a (b)(4) and modifications to chromatography column performance evaluation, be formally reported in the company's next annual report, complete with supporting data to demonstrate comparability and efficacy. These actions are crucial for ensuring ongoing compliance with good manufacturing practices.

Company
AbbVie Bioresearch Center
Inspection date
May 24, 2018
Product type
Biologics
Office
Team Biologics
People
  • Robert T. O"Hagan (recipient)
  • Miriam Ferrell (company_representative)
  • Krista Stanley (company_representative)
  • Douglas Heathcoate (company_representative)
  • Matthew Bennett (company_representative)
View Company Profile

ID · dd106705-3ed4-4568-a1bc-df4b07029ec0

Other documents for AbbVie Bioresearch Center
  • 483 - 2025-12-16December 16, 2025
  • EIR - 2019-11-18November 18, 2019
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore AbbVie Bioresearch Center
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.